Search results for "From ACP Internist Weekly"
USPSTF expands hepatitis C screening recommendation to most adults
All adults ages 18 to 79 years should now be screened at least once, but people who use injection drugs and pregnant women may require screening more often.
https://gastroenterology.acponline.org/archives/2020/03/27/6.htm
27 Mar 2020
AGA releases guidelines on managing gastric intestinal metaplasia found during routine endoscopy
The guidelines from the American Gastroenterological Association (AGA) will aid clinicians' decision making for patients undergoing upper endoscopy in North America, the authors said.
https://gastroenterology.acponline.org/archives/2019/12/27/7.htm
27 Dec 2019
Time of day associated with ordering, completion of cancer screening
An editorial noted that referrals to screening could be handled by other clinic staff, easing the burden on physicians.
https://gastroenterology.acponline.org/archives/2019/05/24/7.htm
24 May 2019
Mucosal healing an emerging goal of ulcerative colitis treatment, guideline states
The updated guideline from the American College of Gastroenterology offers recommendations on drug treatment and cancer screening, among other topics.
https://gastroenterology.acponline.org/archives/2019/03/22/8.htm
22 Mar 2019
ACP issues new guidance on colorectal cancer screening
For asymptomatic, average-risk patients ages 50 to 75 years, the guidance suggests use of a fecal immunochemical test (FIT) or high-sensitivity guaiac-based fecal occult blood test every two years, colonoscopy every 10 years, or flexible sigmoidoscopy every 10 years plus FIT every two years.
https://gastroenterology.acponline.org/archives/2019/11/22/8.htm
22 Nov 2019
Mailing fecal immunochemical tests to patients due for colorectal cancer screening increased screening uptake
Compared with usual care clinics, intervention clinics had a significantly higher adjusted clinic-level proportion of participants who completed a mailed fecal immunochemical test and more participants who completed any colorectal cancer screening.
https://gastroenterology.acponline.org/archives/2018/08/24/8.htm
24 Aug 2018
FIT screening may not be the best method to find right-sided cancers, study indicates
An accompanying editorial noted that fecal immunochemical testing (FIT) may be less effective in the right colon in part because lesions grow more rapidly and bleed less.
https://gastroenterology.acponline.org/archives/2018/10/26/6.htm
26 Oct 2018
FIT may be useful for screening above-average-risk populations for colorectal cancer
A meta-analysis of 12 studies found that fecal immunochemical testing (FIT) may be a viable alternative screening strategy for patients at increased risk for colorectal cancer, but the authors and an accompanying editorial noted that the quality of the evidence was low.
https://gastroenterology.acponline.org/archives/2017/07/28/8.htm
28 Jul 2017
Use of PPIs associated with higher risk of death than use of H2 blockers
Study results should not deter prescription and use of proton pump inhibitors (PPIs) where medically indicated but rather emphasize the need to be judicious about use of PPIs and duration of therapy, the authors said.
https://gastroenterology.acponline.org/archives/2017/07/28/6.htm
28 Jul 2017
Regular use of PPIs linked to increased risk of type 2 diabetes
In an analysis of the Nurses' Health and Health Professionals studies, regular users of proton-pump inhibitors (PPIs) had a 24% higher risk of diabetes than nonusers, with longer duration of use associated with greater risk.
https://gastroenterology.acponline.org/archives/2020/10/23/7.htm
23 Oct 2020